NM SB 14 Comment Letter (2023)
Comment letter for NM SB 14, which includes provisions relating to Dispensing Fees, Steering, AWP, White Bagging, Disclosure, Fiduciary, and Spread Pricing
WY SF 151 Veto Letter (2023)
Veto letter to PBM Omnibus bill, WY SF 151. Provisions include Steering, AWP, Clawback, Fees, MAC, Decline to Fill, Spread Pricing.
IL SB 2008 Cost Analysis Infographic (2021)
Infographic highlighting the estimated cost of IL SB 2008, a bill seeking to enact AWP provisions and a fiduciary mandate.
GA SB 313 Talking Points (2020)
These talking points were developed by PCMA for Georgia SB 313 which includes a fiduciary mandate, prohibition on fees, and PBM-pharmacy contracting.
PCMA Comment Letter ME LD1162 MHDO Informal Rule (2019)
This comment letter was submitted by PCMA to the Maine Health Data Organization regarding the implementation of LD 1162 which would allow the MHDO to
FTC Letter to ERISA Advisory Council Regarding PBM Compensation and Fee Disclosure (2014)
This letter was sent to the ERIS advisory council by the FTC regarding fee and compensation disclosure by PBMs.
Talking Points MD 754 Fees (2019)
These talking points highlight what GER is and the role of PSAOs in establishing these contracting standards on behalf of independent pharmacies.
